An Overview of Troponin

What Is Troponin?

Troponin is a key regulatory protein complex found primarily in cardiac and skeletal muscle and consists of troponin T (TnT), troponin I (TnI), and troponin C (TnC). Troponin plays an important role in muscle contraction and relaxation. TnT attaches troponin complex to actin filaments, TnC acts as a calcium binding site, and TnI inhibits the interaction with myosin head in the absence of sufficient calcium ions.

The action mechanism of troponin complex is mainly achieved by regulating the concentration of calcium in muscle cells: when the muscle is relaxed, the concentration of calcium is low, and TnI binds closely to actin, preventing the interaction between actin and myosin, thus preventing muscle contraction. When the transmission of nerve stimulation leads to the release of calcium ion from sarcoplasmic reticulum and the increase of intracellular calcium concentration, calcium ion binds to TnC, which leads to conformational change of troponin complex, and TnI is removed from actin, which relieves the inhibition of actin-myosin interaction, which makes actin interact with myosin and cause muscle contraction. Currently, cardiac troponins I (cTnI) and T (cTnT) are considered to be key biomarkers in the diagnosis of heart disease. Troponin is released into the blood when cardiomyocytes are damaged, so detection of troponin levels in the blood can help diagnose acute myocardial infarction and other heart injuries, while monitoring its dynamics can also assess the extent of myocardial damage and predict a patient's prognosis.

Figure 1. Atomic models of the cardiac thin filament in the apo-state and Ca²⁺-saturated state
(Source: Tobacman L S. 2021)

Troponin I

Troponin I (TnI) is a critical component of the troponin complex, primarily responsible for inhibiting muscle contraction. In a relaxed muscle state, TnI binds tightly to actin, preventing the interaction between actin and myosin, thus inhibiting muscle contraction. TnI is expressed in three isoforms: cardiac TnI (cTnI), slow skeletal muscle TnI, and fast skeletal muscle TnI. During embryonic development, slow skeletal muscle TnI is expressed in cardiac tissue, but it is replaced by cTnI after birth, which is then exclusively expressed in cardiac tissue. The mature form of human cTnI comprises a 210-residue protein (209 residues after removing the first methionine residue) with a molecular weight of approximately 24kDa. The protein structure includes four alpha helices and a flexible, disordered region in the middle. Structurally, it can be divided into the following domains: the N-terminal domain (NcTnI) unique to the heart, the structurally rigid IT arm, the "inhibitory" peptide, the switch peptide, and the C-terminal domain. Among them, the NcTnI region is only expressed in the cardiac TnI isoform; the IT arm is a rigid coiled coil of the α-helix of cTnI and cTnT; helix H2 is the "inhibitory peptide"; and helix H3 is the switch peptide. Like cTnT, cTnI is widely used in the clinical diagnosis of acute myocardial infarction and in the evaluation of cardiac injury. Elevated levels of cTnI in the blood indicate myocardial cell damage, which is crucial for early diagnosis and intervention in heart conditions.

Figure 3. The cTnI molecule with its relevant structural regions highlighted
(Source: Marston S, et al. 2020)

High-Sensitivity Troponin Detection

The high-sensitivity troponin (hs-troponin) assay technology enables the detection of troponin at concentrations 10 to 100 times lower than conventional assays through improved antibody technology and signal detection methods, while ensuring, among other things, assay accuracy and reproducibility. Designed to detect very small amounts of cTnI and cTnT in the blood, the technology can identify myocardial damage much earlier than conventional tests, which is critical for timely intervention and treatment of AMI. In addition, elevated levels of hs-cTn provide an excellent prognostic indicator for patients with congenital heart disease, atrial fibrillation, heart failure and other conditions.

Figure 4. Distribution of high-sensitivity cardiac troponin T (Panel A) and I (Panel B) Concentrations in Cardio-renal Healthy Asians
(Source: Aw TC, et al. 2019)

Troponin ELISA Kits

Troponin Antigens

Troponin Antibodies